Transactions

March 21 2012

KippsDeSanto & Co. Advises 2020 Company, LLC on its Sale to Acentia

KippsDeSanto & Co. is pleased to send you the attached press release announcing the sale of our client, 2020 Company, LLC (“2020” or “the Company”), to Acentia, a portfolio company of Snow Phipps Group.  Acentia acquired 2020 to deepen its presence in the highly-lucrative Federal healthcare market, expand its information technology (“IT”) capabilities suite, and gain access to 2020’s contracting vehicles.  The transaction closed on March 30, 2012.

Headquartered in Falls Church, VA, 2020 is a leading provider of systems modernization, data collection & analysis, and mission support services, with a sharp focus on the areas of healthcare, education, and science.  The Company directly supports priority mission needs for an array of attractive Federal agencies, such as Centers for Medicare and Medicaid Services (“CMS”), Centers for Disease Control and Prevention (“CDC”), Food and Drug Administration (“FDA”), Department of Education, and National Oceanic and Atmospheric Administration.  The Company has positioned itself squarely in front of enduring funding streams by constructing a portfolio of highly sought-after and utilized contracting vehicles, including the $5 billion CMS Enterprise System Development (“ESD”), the $3 billion CDC Information Management Services (“CIMS”), and the $2 billion FDA Enterprise System Life Cycle Management Support (“ELMS”) contract vehicles.  Underpinned by a robust process-oriented infrastructure, unique level of technical depth, and an industry-recognized management team, 2020 is poised to address Federal clients’ most complex mission challenges such as the implementation of global health data exchanges, modernization of legacy technology infrastructures, and maintenance & overhaul of antiquated Medicaid payment systems.

We believe this transaction demonstrates several key trends in the government technology M&A environment:

• Intense interest from buyers and investors in accessing Federal health markets given strong and long-term anticipated growth

• Continued emphasis on and attraction to high value, long-term contracts and contracting vehicles (e.g., CMS ESD)

• Buyers seeking contractors who provide mission-oriented systems modernization services and high-end development solutions that are critical to the maintenance of legacy technology infrastructures in the Federal space

• Enhanced level of private equity investor participation both as a direct buyer (seeking a platform) and via existing portfolio companies

• The importance and value of a highly-sophisticated, professional back office able to scale alongside growth

LEAD INVESTMENT BANKERS

banker-photo

Bob Kipps

Contact Bob
banker-photo

Marc B. Marlin

Contact Marc

KippsDeSanto & Co. is pleased to send you the attached press release announcing the sale of our client, 2020 Company, LLC (“2020” or “the Company”), to Acentia, a portfolio company of Snow Phipps Group.  Acentia acquired 2020 to deepen its presence in the highly-lucrative Federal healthcare market, expand its information technology (“IT”) capabilities suite, and gain access to 2020’s contracting vehicles.  The transaction closed on March 30, 2012.

Headquartered in Falls Church, VA, 2020 is a leading provider of systems modernization, data collection & analysis, and mission support services, with a sharp focus on the areas of healthcare, education, and science.  The Company directly supports priority mission needs for an array of attractive Federal agencies, such as Centers for Medicare and Medicaid Services (“CMS”), Centers for Disease Control and Prevention (“CDC”), Food and Drug Administration (“FDA”), Department of Education, and National Oceanic and Atmospheric Administration.  The Company has positioned itself squarely in front of enduring funding streams by constructing a portfolio of highly sought-after and utilized contracting vehicles, including the $5 billion CMS Enterprise System Development (“ESD”), the $3 billion CDC Information Management Services (“CIMS”), and the $2 billion FDA Enterprise System Life Cycle Management Support (“ELMS”) contract vehicles.  Underpinned by a robust process-oriented infrastructure, unique level of technical depth, and an industry-recognized management team, 2020 is poised to address Federal clients’ most complex mission challenges such as the implementation of global health data exchanges, modernization of legacy technology infrastructures, and maintenance & overhaul of antiquated Medicaid payment systems.

We believe this transaction demonstrates several key trends in the government technology M&A environment:

• Intense interest from buyers and investors in accessing Federal health markets given strong and long-term anticipated growth

• Continued emphasis on and attraction to high value, long-term contracts and contracting vehicles (e.g., CMS ESD)

• Buyers seeking contractors who provide mission-oriented systems modernization services and high-end development solutions that are critical to the maintenance of legacy technology infrastructures in the Federal space

• Enhanced level of private equity investor participation both as a direct buyer (seeking a platform) and via existing portfolio companies

• The importance and value of a highly-sophisticated, professional back office able to scale alongside growth

LEAD INVESTMENT BANKERS

banker-photo

Bob Kipps

Contact Bob
banker-photo

Marc B. Marlin

Contact Marc